PADMANABHAN SANJEEV R,GOVINDAN LAKSHMANAN,S. SUDHAKARAN,NAMBI SHANTHI,DR. V. SREEDEVI
DOI: https://doi.org/Background: The COVID-19 pandemic significantly impacted global health, with physical health complications receiving the most attention. However, the mental health impact remains less studied. This study aims to address that gap.
Aims: The primary objectives were to assess psychiatric morbidity in COVID-19 patients, examine sociodemographic factors, and correlate psychiatric morbidities with these variables.
Methodology: Conducted between May and August 2021, this observational cross-sectional study included 200 RTPCR-positive individuals with mild COVID-19 symptoms, attending Chengalpattu Government Medical College & Hospital and associated COVID care centers. Patients with comorbid medical/psychiatric illnesses or severe COVID-19 were excluded. Data was collected through a semi-structured sociodemographic and clinical profile, with depression and anxiety screened using PHQ-9 and GAD-7 scales. SPSS version 20.0 was used for statistical analysis.
Statistical analysis used: Correlation study using Chi square analysis, Logistic Regression.
Results: The study revealed that 32% of participants had anxiety and 14% experienced depression. Significant associations were found between anxiety and the Hindu religion, depression and the 18–30 age group. PHQ scores were significantly correlated with age, and a strong positive correlation existed between GAD and PHQ scores.
Conclusion: Despite exposure risks during the peak of the pandemic, psychiatrists conducted field interviews revealing a high prevalence of anxiety and depression among COVID-19 patients. Younger individuals, in particular, require targeted psychiatric interventions to prevent long-term morbidity.
